Home › NDC Lookup › RxCUI directory › RxCUI 1251918

24 HR rotigotine 0.125 MG/HR Transdermal System [Neupro] — RxCUI 1251918

RxNorm drug concept · Semantic branded drug
RxCUI 1251918 Semantic branded drug · SBD ● Current RxNorm concept 7 FDA products 13 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1251918
Official name24 HR rotigotine 0.125 MG/HR Transdermal System [Neupro]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asNeupro 3 MG/Day 24 HR Transdermal Patch; Neupro 3 MG/Day 24HR Transdermal System; 24 HR Neupro 0.125 MG/HR Transdermal System
FDA products mapped7
Package NDCs mapped13
Reported Medicaid activity (SDUD)1,775 prescriptions · 16 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Rotigotine Transdermal Patch: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Neupro treats Parkinson's disease and moderate-to-severe primary Restless Legs Syndrome. Your prescriber will tell you which one it is for in your case.
  • Put on one patch a day at about the same time, on clean, dry, healthy skin. Press it down for 30 seconds, especially around the edges. Pick a new spot each day and don't reuse a sp...
  • Put on a new patch and wear it for the rest of that day. Then go back to your normal routine.
  • What if I forget to change it or it falls off?
📖 Read our full Rotigotine Transdermal Patch guide →

🕸️ Concept Web — How 24 HR rotigotine 0.125 MG/HR Transdermal System... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 24 HR rotigotine 0.125 MG/HR Transdermal System [Neupro] RxCUI 1251918

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Rotigotine 616739
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Neupro 707892
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Rotigotine Transdermal System 1806004
    • Rotigotine Topical Product 1156450
    • Rotigotine Transdermal Product 1295222
    • Rotigotine Transdermal System [Neupro] 1806006
    • Neupro Topical Product 1182282
    • Neupro Transdermal Product 1296451
    • Transdermal System 316987
    • Topical Product 1151122
    • +1 more in this family
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • 24 HR rotigotine 0.125 MG/HR Transdermal System SCD · 1251916
  • Rotigotine 0.125 MG/HR SCDC · 1251915
  • Rotigotine Transdermal System SCDF · 1806004
  • Rotigotine Topical Product SCDG · 1156450
  • Rotigotine Transdermal Product SCDG · 1295222

Brand-Name Concepts

  • Rotigotine 0.125 MG/HR [Neupro] SBDC · 1251917
  • Rotigotine Transdermal System [Neupro] SBDF · 1806006
  • Neupro Topical Product SBDG · 1182282
  • Neupro Transdermal Product SBDG · 1296451
  • Neupro BN · 707892

📦 FDA Products & Package NDCs

7 products · 13 package NDCs
13 package NDCs map to RxCUI 1251918 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
50474-0801-03 30 POUCH in 1 CARTON (50474-801-03) / 1 PATCH in 1 POUCH /... Neupro UCB, Inc. 2012-04-02
50474-0801-17 7 POUCH in 1 CARTON (50474-801-17) / 1 PATCH in 1 POUCH / 2... Neupro UCB, Inc. 2012-04-02
50474-0802-03 30 POUCH in 1 CARTON (50474-802-03) / 1 PATCH in 1 POUCH /... Neupro UCB, Inc. 2012-04-02
50474-0802-17 7 POUCH in 1 CARTON (50474-802-17) / 1 PATCH in 1 POUCH / 2... Neupro UCB, Inc. 2012-04-02
50474-0803-03 30 POUCH in 1 CARTON (50474-803-03) / 1 PATCH in 1 POUCH /... Neupro UCB, Inc. 2012-04-02
50474-0803-17 7 POUCH in 1 CARTON (50474-803-17) / 1 PATCH in 1 POUCH / 2... Neupro UCB, Inc. 2012-04-02
50474-0804-03 30 POUCH in 1 CARTON (50474-804-03) / 1 PATCH in 1 POUCH /... Neupro UCB, Inc. 2012-04-02
50474-0804-17 7 POUCH in 1 CARTON (50474-804-17) / 1 PATCH in 1 POUCH / 2... Neupro UCB, Inc. 2012-04-02
50474-0805-03 30 POUCH in 1 CARTON (50474-805-03) / 1 PATCH in 1 POUCH /... Neupro UCB, Inc. 2012-04-02
50474-0805-17 7 POUCH in 1 CARTON (50474-805-17) / 1 PATCH in 1 POUCH / 2... Neupro UCB, Inc. 2012-04-02
50474-0806-03 30 POUCH in 1 CARTON (50474-806-03) / 1 PATCH in 1 POUCH /... Neupro UCB, Inc. 2012-04-02
50474-0806-17 7 POUCH in 1 CARTON (50474-806-17) / 1 PATCH in 1 POUCH / 2... Neupro UCB, Inc. 2012-04-02
50474-0808-11 2 BOX in 1 KIT (50474-808-11) / 1 KIT in 1 BOX * 7 POUCH i... Neupro UCB, Inc. 2012-04-02
Observed labelers: UCB, Inc. (13) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.